News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,279 Results
Type
Article (8112)
Company Profile (141)
Press Release (479025)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (167096)
Career Advice (309)
Deals (25796)
Drug Delivery (7)
Drug Development (52901)
Employer Resources (14)
FDA (9762)
Job Trends (8576)
News (238602)
Policy (17912)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (493)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (99)
Alliances (33309)
ALS (108)
Alzheimer's disease (985)
Antibody-drug conjugate (ADC) (287)
Approvals (10413)
Artificial intelligence (333)
ASCO (159)
Autoimmune disease (220)
Automation (30)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6964)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (1)
Bladder cancer (139)
Brain cancer (31)
Breast cancer (521)
Cancer (3763)
Cardiovascular disease (226)
Career advice (251)
Career pathing (1)
CAR-T (178)
CDC (1)
CDMO (15)
Celiac Disease (1)
Cell therapy (487)
Cervical cancer (35)
Clinical research (48069)
Collaboration (1283)
Commercialization (3)
Compensation (1534)
Complete response letters (34)
COVID-19 (768)
CRISPR (64)
C-suite (803)
Cystic fibrosis (87)
Data (5853)
Denatured (4)
Depression (106)
Dermatology (67)
Diabetes (354)
Diagnostics (4315)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (159)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73835)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88214)
Executive appointments (714)
FDA (12499)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (948)
Gene editing (126)
Generative AI (11)
Gene therapy (334)
GLP-1 (294)
Government (951)
Grass and pollen (2)
Guidances (282)
Healthcare (9375)
Hematology (94)
HIV (55)
Huntington's disease (23)
IgA nephropathy (68)
Immunology and inflammation (106)
Immuno-oncology (61)
Indications (162)
Infectious disease (961)
Inflammatory bowel disease (128)
Inflation Reduction Act (4)
Influenza (86)
Intellectual property (265)
Interviews (42)
IPO (12421)
IRA (2)
Job creations (1971)
Job search strategy (239)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5199)
Licensing (18)
Liver cancer (45)
Longevity (19)
Lung cancer (542)
Lymphoma (257)
Machine learning (29)
Management (3)
Manufacturing (568)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8684)
Medtech (8843)
Mergers & acquisitions (14434)
Metabolic disorders (726)
mRNA (64)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (227)
Neuropsychiatric disorders (40)
Neuroscience (1870)
NextGen: Class of 2026 (3157)
Non-profit (844)
Obesity (231)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (206)
Parkinson's disease (206)
Partnered (12)
Patents (500)
Patient recruitment (530)
Patient selection (2)
Peanut (32)
People (41415)
Peptides (2)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15531)
Phase 2 (21464)
Phase 3 (14471)
Pipeline (7698)
Policy (18)
Postmarket research (1570)
Preclinical (6563)
Press Release (34)
Prostate cancer (194)
Psychedelics (7)
Radiopharmaceuticals (195)
Rare diseases (588)
Real estate (3033)
Recruiting (6)
Regenerative medicine (2)
Regulatory (14980)
Reports (23)
Research institute (587)
Resumes & cover letters (49)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (163)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2027)
Stomach cancer (3)
Supply chain (51)
Vaccines (342)
Venture capital (17)
Weight loss (75)
Women's health (89)
Date
Today (14)
Last 7 days (291)
Last 30 days (1342)
Last 365 days (19034)
2026 (13640)
2025 (19260)
2024 (23001)
2023 (26573)
2022 (34648)
2021 (37255)
2020 (33572)
2019 (23297)
2018 (17499)
2017 (18800)
2016 (17959)
2015 (24307)
2014 (21729)
2013 (18200)
2012 (20262)
2011 (20513)
2010 (20377)
Location
Africa (237)
Alabama (78)
Alaska (2)
Arizona (311)
Arkansas (11)
Asia (18019)
Australia (2135)
California (12355)
Canada (3238)
China (546)
Colorado (496)
Connecticut (427)
Delaware (214)
Europe (25140)
Florida (1856)
Georgia (398)
Hawaii (3)
Idaho (46)
Illinois (727)
India (52)
Indiana (324)
Iowa (16)
Japan (423)
Kansas (103)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1236)
Massachusetts (8111)
Michigan (314)
Minnesota (572)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (122)
New Hampshire (60)
New Jersey (2693)
New Mexico (12)
New York (2897)
North Carolina (1317)
North Dakota (4)
Northern California (6216)
Ohio (294)
Oklahoma (14)
Oregon (16)
Pennsylvania (2295)
Puerto Rico (21)
Rhode Island (30)
South America (409)
South Carolina (78)
South Dakota (1)
Southern California (5142)
Tennessee (125)
Texas (2005)
United States (40058)
Utah (373)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (956)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
487,279 Results for "microarrays inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Micron Biomedical Secures $4.5 Million Federal Contract to Develop First Dissolvable Microarray Radiation/Nuclear Medical Countermeasure
July 27, 2026
·
7 min read
Press Releases
Thermo Fisher Scientific Fuels the Future of Multi-omics Research with the Launch of Next-Generation Microarray Solution
October 16, 2025
·
4 min read
Press Releases
PEPperPRINT GmbH launches cLIFT technology for next-generation peptide microarrays
June 10, 2025
·
3 min read
Press Releases
CD Genomics Unveils Advanced LncRNA Microarray Service to Accelerate Transcriptomic Research
June 6, 2025
·
1 min read
Deals
Spectrum Solutions Acquires Alimetrix, Inc. and Microarrays, Inc. to Expand Laboratory Products and Testing Capabilities
Spectrum Solutions ® today announced the acquisitions of Alimetrix, Inc. and Microarrays, Inc.
March 7, 2023
·
2 min read
Biotech Beach
Bionano Announces Publication of Largest Prospective Prenatal Study Comparing OGM to Chromosomal Microarray Analysis and Karyotyping
Bionano Genomics, Inc. announced a publication covering the largest independent prospective prenatal study comparing optical genome mapping to a combined workflow of chromosomal microarray analysis and karyotyping.
December 26, 2023
·
7 min read
Press Releases
Bionano Announces Upgrades to its Software and Compute Platforms to Make Analysis of OGM, Microarray and NGS Data Easier, Faster and More Accurate
August 6, 2025
·
8 min read
Press Releases
Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology
June 16, 2025
·
5 min read
Press Releases
AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) multiplex microarray
April 3, 2025
·
4 min read
Press Releases
AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Celiac Disease (CD) multiplex microarray
February 10, 2025
·
4 min read
1 of 48,728
Next
